SDGR
Schrodinger, Inc.
$13.13
-1.13%
2026-05-08
About Schrodinger, Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Key Fundamentals
Forward P/E
-8.13
EPS (TTM)
$-1.40
ROE
-30.1%
Revenue Growth (YoY)
-1.6%
Profit Margin
-40.6%
Debt/Equity
34.13
Price/Book
2.57
Beta
1.58
Market Cap
$950.4M
Avg Volume (10D)
1.5M
Recent Breakout Signals
No recent breakout signals detected for SDGR.
Recent Price Range (60 Days)
60D High
$13.42
60D Low
$10.95
Avg Volume
1.4M
Latest Close
$13.13
Get breakout alerts for SDGR
Sign up for Breakout Scanner to receive daily notifications when SDGR triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Schrodinger, Inc. (SDGR) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors SDGR daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SDGR operates in the Healthcare sector within the Health Information Services industry. Data is provided for informational purposes only and does not constitute financial advice.